1 July 2025

Last updated: Friday 27 June 2025

Research Directory

Stock values decline and companies restructure

Adrenomed prepares global study in septic shock

Oncology pipeline marked by multiple therapy types

Targeting skeletal muscle to treat type 2 diabetes

After three years of Covid, risks to health remain

Immunocore and Gadeta probe gamma delta T cell receptors

Novel oncology drugs approved in a year of change

Q4 2022 Stock Comment

Climate change is transforming infectious disease

Regulatory framework for real-world data progresses